Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 75 results.
User Information
Export Records
  1. 1.   PAM3 protects against DSS-induced colitis by altering the M2:M1 ratio
  2. Horuluoglu, Begum H; Kayraklioglu, Neslihan; Tross,Debra; Klinman,Dennis
  3. Scientific reports. 2020, Apr 08; 10(1): 6078.
  1. 2.   High-throughput single-molecule screen for small-molecule perturbation of splicing and transcription kinetics
  2. Day, C. R.; Chen, H.; Coulon, A.; Meier, J. L.; Larson, D. R.
  3. Methods (San Diego, Calif.). 2016, 1-Mar; 96: 59-68.
  1. 3.   The importance of Raf dimerization in cell signaling
  2. Freeman, A. K.; Ritt, D. A.; Morrison, D. K.
  3. Small GTPases. 2013, Jul-Sep; 4(3): 180-5.
  1. 4.   Intratumoral Injection of CpG Oligonucleotides Induces the Differentiation and Reduces the Immunosuppressive Activity of Myeloid-Derived Suppressor Cells
  2. Shirota, Y.; Shirota, H.; Klinman, D. M.
  3. Journal of Immunology. 2012, Feb; 188(4): 1592-1599.
  1. 5.   IKK alpha represses a network of inflammation and proliferation pathways and elevates c-Myc antagonists and differentiation in a dose-dependent manner in the skin
  2. Liu, B.; Willette-Brown, J.; Liu, S.; Chen, X.; Fischer, S. M.; Hu, Y.
  3. Cell Death and Differentiation. 2011, Dec; 18(12): 1854-1864.
  1. 6.   Drozitumab, a Human Antibody to Death Receptor 5, Has Potent Antitumor Activity against Rhabdomyosarcoma with the Expression of Caspase-8 Predictive of Response
  2. Kang, Z. G.; Chen, J. J.; Yu, Y. K.; Li, B.; Sun, S. Y.; Zhang, B. L.; Cao, L.
  3. Clinical Cancer Research. 2011, May; 17(10): 3181-3192.
  1. 7.   Exposure to HIV-1-encoded Toll-like receptor 8 ligands enhances monocyte response to microbial encoded Toll-like receptor 2/4 ligands
  2. Mureith, M. W.; Chang, J. J.; Lifson, J. D.; Ndung'u, T.; Altfeld, M.
  3. Aids. 2010, Jul; 24(12): 1841-1848.
  1. 8.   Identification and characterization of a novel agonistic anti-DR4 human monoclonal antibody
  2. Feng, Y.; Xiao, X. D.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Mabs. 2010, Sep-Oct; 2(5): 565-570.
  1. 9.   TNF-alpha: an activator of CD4+FoxP3+TNFR2+ regulatory T cells
  2. Chen, X.; Oppenheim, J. J.
  3. Current directions in autoimmunity. 2010 11: 119-34.
  1. 10.   Nuclear export factor RBM15 facilitates the access of DBP5 to mRNA
  2. Zolotukhin, A. S.; Uranishi, H.; Lindtner, S.; Bear, J.; Pavlakis, G. N.; Felber, B. K.
  3. Nucleic Acids Research. 2009, Nov; 37(21): 7151-62.
  1. 11.   Development of HIF-1 inhibitors for cancer therapy
  2. Onnis, B.; Rapisarda, A.; Melillo, G.
  3. Journal of Cellular and Molecular Medicine. 2009, Sep; 13(9A): 2780-6.
  1. 12.   Synthesis and conformational analysis of locked carbocyclic analogues of 1,3-diazepinone riboside, a high-affinity cytidine deaminase inhibitor
  2. Ludek, O. R.; Schroeder, G. K.; Liao, C.; Russ, P. L.; Wolfenden, R.; Marquez, V. E.
  3. Journal of Organic Chemistry. 2009, Aug 21; 74(16): 6212-23.
  1. 13.   Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii
  2. Klausmeyer, P.; Zhou, Q.; Scudiero, D. A.; Uranchimeg, B.; Melillo, G.; Cardellina, J. H.; Shoemaker, R. H.; Chang, C. J.; McCloud, T. G.
  3. Journal of Natural Products. 2009, May 22; 72(5): 805-12.
  1. 14.   Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets
  2. Adamson, C. S.; Freed, E. O.
  3. Molecular Interventions. 2009, Apr; 9(2): 70-4.
  1. 15.   Quassinoid inhibition of AP-1 function does not correlate with cytotoxicity or protein synthesis inhibition
  2. Beutler, J. A.; Kang, M. I.; Robert, F.; Clement, J. A.; Pelletier, J.; Colburn, N. H.; McKee, T. C.; Goncharova, E.; McMahon, J. B.; Henrich, C. J.
  3. Journal of Natural Products. 2009, Mar 27; 72(3): 503-6.
  1. 16.   Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa
  2. Meragelman, T. L.; Scudiero, D. A.; Davis, R. E.; Staudt, L. M.; McCloud, T. G.; Cardellina, J. H. 2nd.; Shoemaker, R. H.
  3. Journal of Natural Products. 2009, Mar 27; 72(3): 336-9.
  1. 17.   Influence of the dual ABCB1 and ABCG2 inhibitor tariquidar on the disposition of oral imatinib in mice
  2. Gardner, E. R.; Smith, N. F.; Figg, W. D.; Sparreboom, A.
  3. Journal of experimental & clinical cancer research : CR. 2009 28: 99.
  1. 18.   Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
  2. Norris, J. D.; Joseph, J. D.; Sherk, A. B.; Juzumiene, D.; Turnbull, P. S.; Rafferty, S. W.; Cui, H. X.; Anderson, E.; Fan, D. J.; Dye, D. A.; Deng, X.; Kazmin, D.; Chang, C. Y.; Willson, T. M.; McDonnell, D. P.
  3. Chemistry & Biology. 2009 16(4): 452-460.
  1. 19.   Targeting the ubiquitin-proteasome system for cancer therapy
  2. Yang, Y. L.; Kitagaki, J.; Wang, H.; Hou, D. X.; Perantoni, A. O.
  3. Cancer Science. 2009 100(1): 24-28.
  1. 20.   Id1 immortalizes hematopoietic progenitors in vitro and promotes a myeloproliferative disease in vivo
  2. Suh, H. C.; Leeanansaksiri, W.; Ji, M.; Klarmann, K. D.; Renn, K.; Gooya, J.; Smith, D.; McNiece, I.; Lugthart, S.; Valk, P. J.; Delwel, R.; Keller, J. R.
  3. Oncogene. 2008, Sep 18; 27(42): 5612-5623.
  1. 21.   SAR by oxime-containing peptide libraries: Application to Tsg101 ligand optimization
  2. Liu, F.; Stephen, A. G.; Waheed, A. A.; Aman, M. J.; Freed, E. O.; Fisher, R. J.; Burke, T. R.
  3. Chembiochem. 2008 9(12): 2000-2004.
  1. 22.   Synthesis of enantiomerically pure (S)-methanocarbaribo uracil nucleoside derivatives for use as antiviral agents and P2Y receptor ligands
  2. Melman, A.; Zhong, M.; Marquez, V. E.; Jacobson, K. A.
  3. Journal of Organic Chemistry. 2008 73(20): 8085-8088.
  1. 23.   Interaction of a cyclic, bivalent Smac mimetic with the X-linked inhibitor of apoptosis protein
  2. Nikolovska-Coleska, Z.; Meagher, J. L.; Jiang, S.; Yang, C. Y.; Qiu, S.; Roller, P. P.; Stuckey, J. A.; Wang, S.
  3. Biochemistry. 2008 47(37): 9811-9824.
  1. 24.   Synthesis of conformationally locked carbocyclic 1,3-diazepinone nucleosides as inhibitors of cytidine deaminase
  2. Ludek, O. R.; Schroeder, G. K.; Wolfenden, R.; Marquez, V. E.
  3. Nucleic acids symposium series (2004). 2008 (52): 659-60.
  1. 25.   Conformational analysis of an alpha 3 beta 1 integrin-binding peptide from thrombospondin-1: Implications for antiangiogenic drug design
  2. Furrer, J.; Luy, B.; Basrur, V.; Roberts, D. D.; Barchi, J. J.
  3. Journal of Medicinal Chemistry. 2006, Oct; 49(21): 6324-6333.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel